<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000631063"><TermName>zafirlukast</TermName><TermPronunciation>(zuh-FER-loo-kast)</TermPronunciation><TermDefinition><DefinitionText>A drug used to prevent and treat symptoms of asthma. It blocks substances that cause inflammation in the lungs. It is a type of antiasthmatic agent and a leukotriene receptor antagonist. Also called Accolate.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000722644" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;zafirlukast&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722643" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;zafirlukast&quot;" language="es" id="_4"/><SpanishTermName>zafirlukast</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para prevenir y tratar los síntomas del asma. Bloquea las sustancias que hacen inflamar los pulmones. Es un tipo de antiasmático y un antagonista del receptor del leucotrieno.  También se llama Accolate.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-12-30</DateFirstPublished></GlossaryTerm>
